evitria Partners with Sapio Sciences to Streamline Antibody Workflow Management and Reporting

After an extensive evaluation process where Sapio demonstrated an understanding of evitria’s complex workflow needs, the company chose Sapio ELN and Sapio Report Builder to streamline complex workflows, and Sapio Report Generator will enable the creation of customized reports directly from the system

Written bySapio Sciences
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.

Zurich-based evitria has established itself as a premier CHO-based transient expression services provider for antibodies and other recombinant proteins, serving a diverse clientele ranging from academic laboratories to global biopharmaceutical companies.

After an extensive evaluation process where Sapio demonstrated an understanding of evitria’s complex workflow needs, the company chose Sapio ELN and Sapio Report Builder to streamline complex workflows, and Sapio Report Generator will enable the creation of customized reports directly from the system.

<b ><span lang="EN-US">Stefan Schmidt, CEO of evitria</span></b>

Stefan Schmidt, CEO of evitria, commented: “Working with Sapio Sciences marks a significant step forward in our workflow and data management capabilities. The highly flexible Sapio solution nicely captures our existing workflows, streamlining data capture and processing, requiring only limited retooling of our processes or retraining for our employees. It also provides a platform for future growth and optimization, and we are confident that this integration will enhance our ability to serve our global client base with even greater efficiency and precision.”




<b ><span lang="EN-US">Mike McCartney, Chief Commercial Officer at Sapio</span></b>

Mike McCartney, Chief Commercial Officer at Sapio, commented: “We are thrilled to partner with evitria, a true innovator in antibody expression services. The Sapio platform was designed to meet the evolving needs of life sciences organizations like evitria, reinforcing our mission to elevate science and empower scientists. Our team’s deep understanding of scientific workflows allowed us to address evitria’s specific needs and showcase our commitment to accelerating discovery and improving lives.”





Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies